MedElevator
Войти в исследования Journal of pain research · 2026
Utility of Peripheral Nerve Block in Lower Extremity Amputation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Onyewu Samuel C, Yanez David, Nnamdi Jude, Onyewu Miriam C, Effraim Philip R
Аннотация
BACKGROUND: Approximately 200,000 limb amputations (LA) occur annually in the United States, with almost two million people living with limb loss. Phantom limb pain (PLP) is a common sequela of LA, and accounts for $12 billion in health care expenditure. The optimal anesthetic modality to reduce PLP and improve perioperative outcomes remains unclear. This study evaluated whether peripheral nerve block (PNB), used as a primary anesthetic modality, improves perioperative outcomes compared with general anesthesia (GA) in lower extremity amputation (LEA).
METHODS: A single-institution retrospective review was conducted of adult patients undergoing first-time LEA between January 2019 and June 2020. Patients were stratified by anesthetic techniques: GA, PNB, neuraxial anesthesia, or GA combined with PNB. Outcomes included incidence of PLP, length of hospital stay, opioid requirements within the first 72 hours, and operative/anesthetic time. Statistical analyses included ANOVA, chi-square testing, and multivariable regression with robust standard errors.
RESULTS: 193 records were reviewed; 179 met inclusion criteria. GA was used in 54% of cases, GA+PNB in 44%, and PNB or neuraxial anesthesia in 2%. Patients receiving PNB alone were older and had higher BMI, with a greater proportion undergoing below-knee amputation. PLP incidence was lower in GA compared with GA+PNB (8% vs 14%), though not statistically significant. Notably, no cases of PLP occurred in patients receiving PNB alone. PNB use was associated with lower opioid requirements and a significant reduction in operative time, while hospital length of stay was similar across groups. Phantom limb pain did not differ significantly between groups (GA+PNB vs GA), OR = 1.94, 95% CI [0.71, 5.28], p =0.196.
CONCLUSION: Overall, PNB demonstrated potential benefits in reducing opioid use and operative time, with promising findings regarding PLP prevention. These results support further prospective, randomized trial of PNB as a primary anesthetic strategy for LEA.
METHODS: A single-institution retrospective review was conducted of adult patients undergoing first-time LEA between January 2019 and June 2020. Patients were stratified by anesthetic techniques: GA, PNB, neuraxial anesthesia, or GA combined with PNB. Outcomes included incidence of PLP, length of hospital stay, opioid requirements within the first 72 hours, and operative/anesthetic time. Statistical analyses included ANOVA, chi-square testing, and multivariable regression with robust standard errors.
RESULTS: 193 records were reviewed; 179 met inclusion criteria. GA was used in 54% of cases, GA+PNB in 44%, and PNB or neuraxial anesthesia in 2%. Patients receiving PNB alone were older and had higher BMI, with a greater proportion undergoing below-knee amputation. PLP incidence was lower in GA compared with GA+PNB (8% vs 14%), though not statistically significant. Notably, no cases of PLP occurred in patients receiving PNB alone. PNB use was associated with lower opioid requirements and a significant reduction in operative time, while hospital length of stay was similar across groups. Phantom limb pain did not differ significantly between groups (GA+PNB vs GA), OR = 1.94, 95% CI [0.71, 5.28], p =0.196.
CONCLUSION: Overall, PNB demonstrated potential benefits in reducing opioid use and operative time, with promising findings regarding PLP prevention. These results support further prospective, randomized trial of PNB as a primary anesthetic strategy for LEA.